On Going Projects

Is there a shared genetic predisposition to both cleft lip and palate and head and neck cancer?

Approved 17 February 2017

Investigating the effect of variants at HLA on risk of HPV status in a clinical cohort of people with head and neck cancer.

Approved 17 February 2017

Experiencing a Diagnosis of Head & Neck Cancer

Approved 26 October 2016

Genetic and Epigenetic Data as a Tool to Understand Oropharyngeal Cancer Incidence and Progression.

Approved 20 January 2017

Head and Neck 5000: A UK multicentre prospective cohort study assessing the relationship between dietary behaviours and survival in head and neck cancer

Approved 20 January 2017

Does early delivery of specialist palliative care offer enhanced support to patients with head and neck cancer

Approved 20 January 2017

Association of comorbid burden with survival in head and neck cancer: A UK multicentre prospective cohort study

Approved 11 November 2016
Exploring mechanisms linking lifestyle and dietary factors to oral and oropharyngeal cancer progression

Approved 26 October 2016

Smoking and alcohol survival analysis in Head and neck 5000

Approved 26 October 2016

Investigation of survival outcomes associated with socioeconomic status

Approved 18 October 2016

A national audit to assess adherence to Royal College of Pathologists guidelines for MDS reporting of Oral Squamous Cell Carcinoma

Approved 12 August 2016

Depression and survival among head and neck cancer patients

Approved 17 June 2016

Defining groups of patients using the EORTC C30. EORTC H&N35. EQ5D-5L and UW-QOL as part screening in clinical practice

Approved 17 June 2016

Assessing the validity of the EQ5D-5L Quality of Life questionnaire

Approved 17 June 2016

What will I be like one year after head and neck cancer treatment?

Approved 17 June 2016
HRQOL as a predictor of survival

Approved 17 June 2016

Factors that determine health related quality of life one year following the diagnosis of head and neck cancer

Approved 17 June 2016

Trajectory, determinants and sequelae of speech, voice and swallowing in people with head and neck cancer

_{Approved 17 June 2016}

A descriptive analysis of maxillary and paranasal sinus tumours from Head and Neck 5000

Approved 20 May 2016

A descriptive analysis of nasopharyngeal tumours from Head & Neck 5000

Approved 20 May 2016

A descriptive analysis of the  nasal cavity tumours from Head & Neck 5000

Approved 20 May 2016

The construction of a percentile calculator for identifying the rarity of fears of cancer (FCR) in head and neck cancer patients

Approved 15 April 2016

The design and testing of path model to summarise the development of distress and fears of recurrence in patients with head & neck cancer one year following diagnosis

Approved 15 April 2016

Genome wide association study of oral and oropharyngeal cancer using the oncochip

Approved 15 April 2016

Identifying epigenetic biomarkers in cancers of the head and neck

Approved 15 April 2016

Human papilloma virus serology in participants in Head & Neck 5000

Approved 15 April 2016

Vitamin D and head and neck cancer risk and progression. An examination of causality and mechanisms

Approved 15 April 2016